Literature DB >> 21735078

Continuous glucose monitoring in gastroparesis.

Zeeshan Ramzan1, Frank Duffy, Javier Gomez, Robert S Fisher, Henry P Parkman.   

Abstract

BACKGROUND: Delayed gastric emptying can alter glucose levels in diabetic patients; hyperglycemia can delay gastric emptying. Continuous glucose monitoring (CGM) may be useful to assess the relationship between gastric emptying and blood glucose levels. AIMS: The aims of this study were to compare the postprandial blood glucose profile of patients with type 2 diabetes mellitus (T2DM) with and without gastroparesis, normal subjects, and patients with idiopathic gastroparesis (IG), and also to determine the effect of different meal compositions on glucose regulation in T2DM and normals.
METHODS: Seven patients with IG, seven T2DM with gastroparesis, ten non-gastroparetic T2DM, and ten normal subjects underwent CGM during a low fat (Eggbeaters) meal. Glucose profiles were also studied in T2DM and normal subjects after high fat, high fiber, spicy, and Ensure liquid nutrient meals.
RESULTS: After the Eggbeaters meal, the glucose profile of IGs and normals were similar. Diabetic patients with gastroparesis had similar peak postprandial blood glucose to nongastroparetic diabetics (231 ± 26 vs. 232 ± 18 mg/dl), but had a higher postprandial blood glucose at the end of the 4 h study (187 ± 26 mg/dl vs. 97 ± 10; P = 0.01). In contrast to normals, non-gastroparetic diabetics had higher mean postprandial blood sugar after the Eggbeaters meal (173 ± 5 mg/dl) compared to high fat (157 ± 3; P = 0.002), spicy (133 ± 2; P < 0.001) and Ensure meals (152 ± 1; P < 0.001).
CONCLUSIONS: Blood glucose monitoring provides insight to the presence of gastroparesis in diabetic patients: diabetic gastroparetics had prolonged postprandial hyperglycemic profile as compared to non-gastroparetic diabetics. Of the meals tested, the low fat (Eggbeaters) meal was associated with the highest mean postprandial glucose in diabetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735078     DOI: 10.1007/s10620-011-1810-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Effects of chili consumption on postprandial glucose, insulin, and energy metabolism.

Authors:  Kiran Dk Ahuja; Iain K Robertson; Dominic P Geraghty; Madeleine J Ball
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

2.  Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

Authors:  Robert Tanenberg; Bruce Bode; Wendy Lane; Claresa Levetan; Jorge Mestman; Anne Peters Harmel; Janet Tobian; Todd Gross; John Mastrototaro
Journal:  Mayo Clin Proc       Date:  2004-12       Impact factor: 7.616

Review 3.  Decelerating gastric emptying: therapeutic possibilities in type 2 diabetes.

Authors:  W T Phillips; J G Schwartz
Journal:  Diabet Med       Date:  1996-09       Impact factor: 4.359

4.  Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients.

Authors:  T K Ray; K M Mansell; L C Knight; L S Malmud; O E Owen; G Boden
Journal:  Am J Clin Nutr       Date:  1983-03       Impact factor: 7.045

5.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

6.  Assessment of gastric emptying using a low fat meal: establishment of international control values.

Authors:  G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

7.  Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.

Authors:  M F Kong; P King; I A Macdonald; T A Stubbs; A C Perkins; P E Blackshaw; C Moyses; R B Tattersall
Journal:  Diabetologia       Date:  1997-01       Impact factor: 10.122

8.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

Authors:  D A Revicki; A M Rentz; D Dubois; P Kahrilas; V Stanghellini; N J Talley; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

10.  Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying.

Authors:  W T Phillips; J G Schwartz; C A McMahan
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

View more
  10 in total

1.  Gender and estradiol as major factors in the expression and dimerization of nNOSα in rats with experimental diabetic gastroparesis.

Authors:  M Showkat Ali; Iliana Tiscareno-Grejada; Silviu Locovei; Rebecca Smiley; Todd Collins; Jerzy Sarosiek; Richard McCallum
Journal:  Dig Dis Sci       Date:  2012-06-10       Impact factor: 3.199

2.  Diabetic Gastroparesis.

Authors:  Adil E Bharucha; Yogish C Kudva; David O Prichard
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

3.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15

4.  Postprandial plasma glucose response and gastrointestinal symptom severity in patients with diabetic gastroparesis.

Authors:  Eva A Olausson; Håkan Grundin; Mats Isaksson; Christina Brock; Asbjørn M Drewes; Stig Attvall; Magnus Simrén
Journal:  J Diabetes Sci Technol       Date:  2014-05-06

5.  Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes.

Authors:  K L Koch; W L Hasler; K P Yates; H P Parkman; P J Pasricha; J Calles-Escandon; W J Snape; T L Abell; R W McCallum; L A Nguyen; I Sarosiek; G Farrugia; J Tonascia; L Lee; L Miriel; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2016-03-06       Impact factor: 3.598

6.  Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry.

Authors:  Grazia Aleppo; Peter Calhoun; Nicole C Foster; David M Maahs; Viral N Shah; Kellee M Miller
Journal:  J Diabetes Complications       Date:  2017-09-06       Impact factor: 2.852

7.  Classification of Gastroparesis from Glycemic Variability in Type 1 Diabetes: A Proof-of-Concept Study.

Authors:  Simon Lebech Cichosz; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2021-05-15

Review 8.  Atypical mechanism of glucose modulation by colesevelam in patients with type 2 diabetes.

Authors:  Oliseyenum M Nwose; Michael R Jones
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-12-08

Review 9.  Gastroparesis: concepts, controversies, and challenges.

Authors:  Klaus Bielefeldt
Journal:  Scientifica (Cairo)       Date:  2012-08-08

Review 10.  Diabetic Gastroparesis: Principles and Current Trends in Management.

Authors:  Sathya Krishnasamy; Thomas L Abell
Journal:  Diabetes Ther       Date:  2018-06-22       Impact factor: 2.945

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.